The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
US FDA approval based on NEURO-TTRansform Phase III results
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
The announcement follows FDA 510(k) clearance of device
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The drug is also intended for the treatment of glioblastoma multiforme
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
Subscribe To Our Newsletter & Stay Updated
